Grand Pharmaceutical Group Ltd Reg.Ajusted Shares HD -,01
- BID
0.56
- ASK
0.6
- 3,750 Units3,500 Units
- 07/23, 21:59:14 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
42.56%
Market Cap
-
P/E Ratio
22.15
Dividend Yield
2.15 %
Earnings per Share
0.04 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.56 G | 0 Units |
| PRICE DETERMINATION TIME | 07/23/2026 / 09:57:01 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.58 | 0.56 |
| PREV. DAY'S PRICE | 0.59 | (07/22) |
| CHANGE DAY BEFORE | -0.03 | -5.08 % |
| 52 WEEK HIGH / LOW | 1.01 (08/22) | 0.486 (06/26) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.06 | 0.08 | 0.04 | 0.06 | 0.07 |
DIVIDENDS PER SHARE | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 |
DIVIDEND YIELD IN % | 6.36 % | 5.42 % | 2.15 % | - | - |
DIVIDEND GROWTH IN % | 80.68 % | 0.28 % | -37.62 % | - | - |
PRICE - EARNINGS RATIO | 7.63 | 6.81 | 22.15 | 9.50 | 8.44 |
PRICE - BOOK RATIO | 0.94 | 1.02 | 1.62 | - | - |
PRICE - SALES RATIO | 1.36 | 1.44 | 2.24 | - | - |
PRICE - CASH FLOW RATIO | 6.44 | 9.75 | 18.32 | - | - |
Master Data
| WKN | A0Q8LD |
| ISIN | BMG210A71016 |
| SYMBOL | MX6A |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | GRAND PHARM. GRP. HD-,01 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -4.27 % | 7.69 % | -17.65 % | -30.86 % | -42.56 % | 20.69 % | -17.43 % | -32.53 % |
| HIGH | 0.59 | 0.60 | 0.69 | 0.88 | 1.01 | 1.03 | 1.03 | 0.88 |
| LOW | 0.55 | 0.49 | 0.49 | 0.49 | 0.49 | 0.37 | 0.37 | 0.49 |
Dividende
pro Aktie
Company profile
Grand Pharmaceutical Group Ltd. is an investment holding company, which engages in the development, manufacture and distribution of pharmaceutical products. The firm offers ophthalmic medicines for anti-bacterial, antibiotics, antipyretic and analgesic use. It operates through the following geographical segments: The People's Republic of China (PRC), America, Europe, Asia other than the PRC, and Others. The company was founded on October 18, 1995 and is headquartered in Hong Kong.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.